TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: vepdegestrant|DRUG: Samuraciclib
Sponsor: Pfizer
Collaborators: Arvinas Estrogen Receptor, Inc.|Carrick Therapeutics Limited